Choksi Asia Ltd
₹ 106
-0.56%
16 Jun
- close price
About
Incorporated in 1992, Choksi Imaging Ltd manufactures and trades X-ray films that find application in medical imaging. In addition, it is engaged in the trading of various items used in the healthcare industry.
Key Points
- Market Cap ₹ 41.3 Cr.
- Current Price ₹ 106
- High / Low ₹ 125 / 62.0
- Stock P/E 13.3
- Book Value ₹ 94.6
- Dividend Yield 0.00 %
- ROCE 18.4 %
- ROE 11.9 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.12 times its book value
- Debtor days have improved from 105 to 82.2 days.
Cons
- Company has a low return on equity of 3.79% over last 3 years.
- Contingent liabilities of Rs.17.2 Cr.
- Earnings include an other income of Rs.1.58 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
170.21 | 108.03 | 45.96 | 27.26 | 23.08 | 17.33 | 16.00 | 11.16 | 2.46 | 0.77 | 1.27 | 36.98 | |
172.79 | 106.19 | 43.40 | 26.31 | 21.77 | 17.75 | 17.42 | 12.85 | 3.92 | 2.21 | 3.12 | 33.17 | |
Operating Profit | -2.58 | 1.84 | 2.56 | 0.95 | 1.31 | -0.42 | -1.42 | -1.69 | -1.46 | -1.44 | -1.85 | 3.81 |
OPM % | -1.52% | 1.70% | 5.57% | 3.48% | 5.68% | -2.42% | -8.88% | -15.14% | -59.35% | -187.01% | -145.67% | 10.30% |
0.06 | 0.07 | 0.40 | 0.43 | 0.74 | 1.64 | 1.06 | 4.58 | 1.14 | 1.16 | 1.04 | 1.58 | |
Interest | 3.29 | 1.56 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 |
Depreciation | 0.60 | 0.44 | 0.41 | 0.39 | 0.22 | 0.21 | 0.17 | 0.19 | 0.17 | 0.16 | 0.16 | 0.18 |
Profit before tax | -6.41 | -0.09 | 2.18 | 0.99 | 1.83 | 1.01 | -0.53 | 2.70 | -0.49 | -0.44 | -0.97 | 4.73 |
Tax % | 0.94% | -577.78% | 0.92% | 22.22% | 30.05% | 14.85% | 5.66% | 29.26% | -12.24% | 6.82% | -53.61% | 34.25% |
-6.46 | 0.42 | 2.17 | 0.77 | 1.29 | 0.86 | -0.56 | 1.91 | -0.42 | -0.48 | -0.46 | 3.10 | |
EPS in Rs | -16.56 | 1.08 | 5.56 | 1.97 | 3.31 | 2.21 | -1.44 | 4.90 | -1.08 | -1.23 | -1.18 | 7.95 |
Dividend Payout % | 0.00% | 46.43% | 17.97% | 37.99% | 22.67% | 22.67% | 0.00% | 51.05% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -10% |
5 Years: | 18% |
3 Years: | 147% |
TTM: | 2812% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 50% |
3 Years: | 111% |
TTM: | 774% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 50% |
3 Years: | 43% |
1 Year: | 56% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 4% |
3 Years: | 4% |
Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 11.09 |
Reserves | 8.78 | 8.31 | 10.01 | 10.99 | 11.92 | 12.42 | 11.62 | 13.53 | 12.09 | 11.62 | 11.16 | 25.79 |
17.65 | 6.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.77 | |
23.63 | 17.09 | 22.45 | 20.80 | 20.88 | 20.91 | 20.08 | 3.79 | 2.42 | 2.53 | 1.91 | 5.53 | |
Total Liabilities | 53.96 | 35.73 | 36.36 | 35.69 | 36.70 | 37.23 | 35.60 | 21.22 | 18.41 | 18.05 | 16.97 | 47.18 |
10.10 | 8.81 | 8.50 | 8.03 | 7.81 | 7.51 | 7.34 | 6.12 | 5.95 | 5.79 | 5.63 | 15.58 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 3.87 | 7.49 | 5.36 | 2.93 | 6.87 | 0.78 | 3.35 | 0.00 | 0.00 | 0.00 |
43.86 | 26.92 | 23.99 | 20.17 | 23.53 | 26.79 | 21.39 | 14.32 | 9.11 | 12.26 | 11.34 | 31.60 | |
Total Assets | 53.96 | 35.73 | 36.36 | 35.69 | 36.70 | 37.23 | 35.60 | 21.22 | 18.41 | 18.05 | 16.97 | 47.18 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15.67 | 10.64 | 7.93 | 1.65 | 5.49 | 2.42 | -2.52 | -2.82 | -0.56 | -2.52 | 0.70 | -2.87 | |
-0.30 | -0.12 | -0.17 | -0.01 | 0.00 | 0.58 | -0.01 | 1.96 | -2.49 | 3.35 | 0.00 | 0.63 | |
-15.01 | -11.45 | -6.90 | 0.00 | -0.35 | -0.35 | -0.24 | 0.00 | -0.98 | 0.00 | 0.00 | -1.20 | |
Net Cash Flow | 0.36 | -0.94 | 0.86 | 1.65 | 5.14 | 2.64 | -2.77 | -0.85 | -4.02 | 0.83 | 0.69 | -3.43 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 49.43 | 32.77 | 63.45 | 78.86 | 106.43 | 103.41 | 107.68 | 32.71 | 89.02 | 180.13 | 51.73 | 82.22 |
Inventory Days | 33.90 | 46.51 | 101.48 | 125.37 | 89.13 | 155.93 | 112.84 | 34.47 | 71.32 | 1,971.00 | 367.52 | 106.20 |
Days Payable | 44.60 | 53.76 | 209.89 | 350.06 | 406.96 | 502.85 | 531.07 | 44.81 | 27.27 | 87.60 | 0.00 | 39.44 |
Cash Conversion Cycle | 38.73 | 25.52 | -44.96 | -145.82 | -211.39 | -243.51 | -310.55 | 22.37 | 133.08 | 2,063.53 | 419.25 | 148.99 |
Working Capital Days | 38.73 | 25.78 | -12.31 | -74.85 | -114.50 | -139.43 | -178.17 | 77.19 | 381.32 | 2,360.65 | 985.79 | 156.25 |
ROCE % | -7.60% | 6.00% | 15.67% | 6.53% | 9.64% | 5.66% | -3.33% | 16.39% | -2.93% | -2.79% | -6.34% | 18.37% |
Documents
Announcements
-
Announcement Under Regulation 30 - Intimation Of Change In Promoter Group Of The Company Pursuant To Scheme Of Amalgamation.
4 Jun - Promoter group updated post-amalgamation; six added, Choksi Asia Pvt Ltd removed.
-
Announcement Under Regulation 30 - Disclosures Under 10(6) And 29(2) Of SEBI (SAST) Regulations, 2011 For Acquisition Of Shares By Members Of Transferor Company, Pursuant To Scheme Of Amalgamation.
4 Jun - Promoters acquired ~24% shares each in Choksi Asia Ltd via Scheme of Amalgamation on May 29, 2025.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report filed for FY ended March 31, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Newspaper publication - Audited Financial Results for the quarter and year ended March 31, 2025.
- Audited Financial Results For The Quarter And Year Ended March 31, 2025. 29 May
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio:[1]
a) Ultrasound and Color Doppler[2]
b) X-Ray Films & Chemicals[3]
c) X-Ray Accessories[4]
d) NDT[5]